Ahrén, B. 2013. Incretin therapy for type 2 diabetes: GLP-1 receptor agonists and DPP-4 inhibitors. International Diabetes Nursing. 10, 1 (Feb. 2013), 31–36. DOI:https://doi.org/10.1002/edn.221.